205 related articles for article (PubMed ID: 24187448)
1. Virus entry mediated by hepatitis B virus envelope proteins.
Taylor JM
World J Gastroenterol; 2013 Oct; 19(40):6730-4. PubMed ID: 24187448
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of hepatitis B and C virus envelope glycoproteins.
Jeulin H; Velay A; Murray J; Schvoerer E
World J Gastroenterol; 2013 Feb; 19(5):654-64. PubMed ID: 23429668
[TBL] [Abstract][Full Text] [Related]
3. Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus.
Freitas N; Abe K; Cunha C; Menne S; Gudima SO
J Virol; 2014 Jun; 88(11):6255-67. PubMed ID: 24648462
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus receptors and molecular drug targets.
Verrier ER; Colpitts CC; Sureau C; Baumert TF
Hepatol Int; 2016 Jul; 10(4):567-73. PubMed ID: 26979861
[TBL] [Abstract][Full Text] [Related]
5. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.
Yan H; Zhong G; Xu G; He W; Jing Z; Gao Z; Huang Y; Qi Y; Peng B; Wang H; Fu L; Song M; Chen P; Gao W; Ren B; Sun Y; Cai T; Feng X; Sui J; Li W
Elife; 2012 Nov; 1():e00049. PubMed ID: 23150796
[TBL] [Abstract][Full Text] [Related]
6. Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B.
Mitra B; Thapa RJ; Guo H; Block TM
Antiviral Res; 2018 Oct; 158():185-198. PubMed ID: 30145242
[TBL] [Abstract][Full Text] [Related]
7. Strategies to inhibit entry of HBV and HDV into hepatocytes.
Urban S; Bartenschlager R; Kubitz R; Zoulim F
Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
[TBL] [Abstract][Full Text] [Related]
8. Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies.
Julithe R; Abou-Jaoudé G; Sureau C
J Virol; 2014 Aug; 88(16):9049-59. PubMed ID: 24899172
[TBL] [Abstract][Full Text] [Related]
9. Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus.
Gudima S; Meier A; Dunbrack R; Taylor J; Bruss V
J Virol; 2007 Apr; 81(8):4343-7. PubMed ID: 17251287
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism.
Watashi K; Wakita T
Cold Spring Harb Perspect Med; 2015 Aug; 5(8):a021378. PubMed ID: 26238794
[TBL] [Abstract][Full Text] [Related]
11. Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection
Beilstein F; Blanchet M; Vaillant A; Sureau C
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212929
[TBL] [Abstract][Full Text] [Related]
12. Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections.
Tu T; Urban S
Curr Opin Virol; 2018 Jun; 30():68-79. PubMed ID: 29775812
[TBL] [Abstract][Full Text] [Related]
13. Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus.
Sureau C; Fournier-Wirth C; Maurel P
J Virol; 2003 May; 77(9):5519-23. PubMed ID: 12692255
[TBL] [Abstract][Full Text] [Related]
14. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
[TBL] [Abstract][Full Text] [Related]
15. Molecular virology of hepatitis B virus and targets for antiviral intervention.
Glebe D; König A
Intervirology; 2014; 57(3-4):134-40. PubMed ID: 25034480
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis delta: A state-of-the-art review and new therapies.
Gilman C; Heller T; Koh C
World J Gastroenterol; 2019 Aug; 25(32):4580-4597. PubMed ID: 31528088
[TBL] [Abstract][Full Text] [Related]
19. The translocation motif of hepatitis B virus envelope proteins is dispensable for infectivity.
Lepère C; Régeard M; Le Seyec J; Gripon P
J Virol; 2007 Jul; 81(14):7816-8. PubMed ID: 17494068
[TBL] [Abstract][Full Text] [Related]
20. Analysis of hepatitis B virus envelope proteins in assembly and infectivity of human hepatitis delta virus.
Sureau C; Lanford R
Prog Clin Biol Res; 1993; 382():45-51. PubMed ID: 8502715
[No Abstract] [Full Text] [Related]
[Next] [New Search]
